Description
Overview
Rigin (palmitoyl tetrapeptide-7) is a palmitoylated fragment of immunoglobulin G. It is studied primarily for its effect on interleukin-6 (IL-6), an inflammatory signaling molecule whose production increases with age and ultraviolet exposure and is linked to matrix breakdown. Rigin is one of the two peptides in the Matrixyl 3000 formulation, combined with palmitoyl tripeptide-1 (Pal-GHK).
Peptide Sciences Bio supplies Rigin (palmitoyl tetrapeptide-7) 200mg as a bulk lyophilized powder for in-vitro and cosmetic formulation research. Every batch is supported by independent analytical testing and a published Certificate of Analysis.
Product Specifications
| Product | Rigin |
|---|---|
| Quantity | 200mg per vial |
| Class | Anti-inflammatory signal peptide |
| INCI name | Palmitoyl Tetrapeptide-7 (formerly Palmitoyl Tetrapeptide-3) |
| Sequence | Pal-Gly-Gln-Pro-Arg |
| Length | 4 amino acids + palmitoyl group |
| Molecular weight | ≈694.9 g/mol |
| CAS number | 221227-05-0 |
| Form | Lyophilized powder (bulk, for formulation research) |
| Purity | ≥99% (HPLC) |
| Documentation | Batch-specific Certificate of Analysis |
Research Background
The dermis is supported by an extracellular matrix of collagen, elastin, fibronectin and glycosaminoglycans, produced mainly by fibroblasts. With age and ultraviolet exposure, matrix production declines and breakdown by matrix metalloproteinases (MMPs) increases. “Signal peptides” are short sequences, often fragments of matrix proteins, that are studied for their ability to stimulate fibroblasts to produce new matrix. Many are attached to palmitic acid (palmitoylated) to improve their penetration through the skin barrier in formulation research.
Structure & Design
The Gly-Gln-Pro-Arg sequence corresponds to a fragment of immunoglobulin G. Palmitoylation improves its lipophilicity for formulation research.
Mechanisms Studied
Research on Rigin has examined:
- IL-6 reduction: lower basal and UV-induced IL-6 in keratinocyte and fibroblast cultures.
- Inflammation-matrix link: research on reduced inflammatory signaling and matrix degradation.
- Synergy with Pal-GHK: combined research in Matrixyl 3000.
Areas of Study
- Skin inflammation (“inflammaging”) research
- Dermal matrix research
- Signal peptide formulation science
These findings come from laboratory and animal research. Rigin has not been established as safe or effective in human clinical trials.
Related Research Peptides
- Matrixyl 200mg (Topical)
- Pal-GHK 200mg (Palmitoyl Tripeptide-1) (Topical)
- Syn-Coll (Palmitoyl Tripeptide-5) 200mg (Topical)
- Tripeptide-29 200mg (Collagen Peptide) (Topical)
- GHK-Cu 200mg (Copper Peptide) (Topical)
Quality & Testing
Every batch of Rigin is independently tested for identity and purity before release. Testing includes high-performance liquid chromatography (HPLC) to confirm purity and mass spectrometry (MS) to confirm molecular identity. The batch-specific Certificate of Analysis is available on this page and in our COA library, so researchers can verify the exact material they receive.
Storage & Handling
- Store lyophilized Rigin at −20°C, protected from light and moisture.
- Short-term storage at 2–8°C is acceptable for lyophilized material.
- Allow the vial to reach room temperature before opening to limit condensation.
- Handle using standard laboratory practices and appropriate protective equipment.
For laboratory solution preparation, see our Peptide Reconstitution Guide.
Frequently Asked Questions
What is Rigin?
Rigin (palmitoyl tetrapeptide-7) is a palmitoylated tetrapeptide studied for reducing IL-6 production in skin cells.
Is Rigin approved for human use?
No. Rigin is not approved by the FDA or any other regulatory agency for human or veterinary use. Peptide Sciences Bio sells it strictly for laboratory research.
How should Rigin be stored?
Lyophilized Rigin should be stored at −20°C, away from light and moisture. Short-term storage at 2–8°C is acceptable.
What does the Certificate of Analysis include?
Each COA reports the batch number, HPLC purity results and mass spectrometry confirmation of molecular identity for that specific batch.
Research Use Only
This product is intended solely for in-vitro research and laboratory experimentation by qualified professionals. It is not a drug, food, supplement or cosmetic, and it is not intended for human or veterinary use, or for the diagnosis, treatment or prevention of any condition. Purchase is restricted to buyers who agree to our Terms of Sale.
Additional information
| Product Form | Topical Powder |
|---|
Rigin 200mg (Palmitoyl Tetrapeptide-7) (Topical)
$200.00
Rigin (palmitoyl tetrapeptide-7) 200mg is a palmitoylated tetrapeptide studied for reducing interleukin-6 production in skin cells. Supplied as a bulk lyophilized powder for formulation research, with batch-specific COA available. For laboratory research use only.
Worldwide tracked delivery. Dispatched within 24 hours of order confirmation.
Not satisfied? Return any item within 10 days for a full refund, no questions asked.



